Amgen (AMGN) EVP Esteban Santos exercises options and sells 54,792 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Amgen EVP of Operations Esteban Santos exercised stock options and sold shares. On February 26, 2026, he exercised nonqualified stock options for 30,501 and 24,291 shares of Amgen common stock at exercise prices of $162.6000 and $177.4600 per share, respectively, and received common stock through derivative exercises.
On the same date, he sold 30,501 and 24,291 shares of common stock in open-market transactions at an average price of $379.1173 per share, for total sales of 54,792 shares, including shares sold to cover the option exercise price and required withholding taxes. After these transactions, he directly owned 76,618 shares and held an additional 903.8036 shares indirectly through the company’s 401(k) plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 54,792 shares ($20,772,595)
Net Sell
7 txns
Insider
Santos Esteban
Role
EVP, Operations
Sold
54,792 shs ($20.77M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Nqso (Right to Buy) | 30,501 | $0.00 | -- |
| Exercise | Nqso (Right to Buy) | 24,291 | $0.00 | -- |
| Exercise | Common Stock | 30,501 | $162.60 | $4.96M |
| Sale | Common Stock | 30,501 | $379.1173 | $11.56M |
| Exercise | Common Stock | 24,291 | $177.46 | $4.31M |
| Sale | Common Stock | 24,291 | $379.1173 | $9.21M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Nqso (Right to Buy) — 0 shares (Direct);
Common Stock — 107,119 shares (Direct);
Common Stock — 903.804 shares (Indirect, 401K Plan)
Footnotes (1)
- Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options. The price reported is an average price of $379.1173 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer These shares include 624 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
FAQ
What did Amgen (AMGN) EVP Esteban Santos report on this Form 4?
Amgen EVP of Operations Esteban Santos reported exercising nonqualified stock options and related open-market sales. He converted options into common shares, then sold 54,792 shares, including shares used to cover exercise costs and required withholding taxes, all on February 26, 2026.
What option exercises did Esteban Santos disclose for Amgen (AMGN)?
He disclosed exercising two nonqualified stock option grants covering 30,501 and 24,291 shares. The underlying options had exercise prices of $162.6000 and $177.4600 per share, respectively, and were exercised on February 26, 2026, converting derivative awards into Amgen common stock.
What were Esteban Santos’s Amgen (AMGN) holdings after these transactions?
Following the reported exercises and sales, Esteban Santos directly held 76,618 Amgen common shares. He also indirectly held 903.8036 additional shares through the company’s 401(k) plan, representing interests in Amgen’s stock fund as of the filing date.